In addition, this study found that the sensitivity, characteristic, accuracy, established predicted worth, and destructive predicted worth of preoperative NMP22 combined with CSTB in assessing bladder carcinoma recurrence after surgery were greater than those of preoperative NMP22 and CSTB alone, and the discrepancies were obvious. This evidence concerns the gene CSTB and urinary bladder carcinoma.